RxDoctor Payments Data

Kevin Hur, MD

Otolaryngology · Arcadia, CANPI 1679996102

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,824 of the $13,002 with a category attached, or 60.2%. Sanofi accounts for 70.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2024 at $9,108 and has fallen 75.7% since, to $2,211 in 2025. Among otolaryngology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,002in general payments, 2019–2025

Across 38 payments — averaging $342.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$9K
  • Medtronic$2K
  • Stryker$414
  • Intersect ENT, Inc.$270
  • Regeneron Healthcare Solutions, Inc.$203
  • Aerin Medical Inc.$198
  • plus $456 from 6 others
$31,484in research payments, 2019–2025

Across 6 payments — averaging $5247.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$21K
  • GSK$10K

What the payments were for

  • Consulting fees$7,82460%
  • Travel & lodging$2,62020%
  • Food & beverage$2,39218%
  • Education$1671%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,002 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California

Medicare billing

Part B allowed, 2024
$165,075
Medicare patients
251
Services billed
935

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XhanceFluticasone Propionate16$9,709
Ipratropium Bromide59$2,119
Azelastine Hcl22$745
Fluticasone Propionate27$506
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav29$269
Doxycycline Hyclate11$79
Prednisone13$12

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Arcadia

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →